We use cookies to personalise content, analyse traffic and provide adverts via a third party. For more information on how we use cookies read our cookie policy in full.
You can change your cookie settings at any time, but parts of our site will not function correctly without them. Learn more about cookies.

• Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
• Avoid Surgical Innovations Group (SUN) by Steve Moore in ShareProphets
• Outperform OSB Group (OSB) by RBC Capital
• Buy Diageo (DGE) by Harvey Jones in The Motley Fool
• Watch Nexteq (NXQ) by Steve Moore in ShareProphets
• Overweight Jet2 (JET2) by Barclays
• Outperform IntegraFin Holding (IHP) by RBC Capital
• Outperform Volution Group (FAN) by RBC Capital
• Sector Perform Currys (CURY) by RBC Capital
• Buy AstraZeneca (AZN) by Robert Stephens (The Times) in The Times - Tempus
• Avoid Facilities by ADF (ADF) by Steve Moore in ShareProphets
• Buy Tribal Group (TRB) by Hot Stock Rockets in ShareProphets
• Avoid Bunzl (BNZL) by Steve Moore in ShareProphets
• Buy FRP Advisory Group (FRP) by Berenberg
• Buy Beeks Financial Cloud Group (BKS) by Canaccord Genuity
• Buy Harbour Energy (HBR) by Canaccord Genuity
• Avoid The Character Group (CCT) by Steve Moore in ShareProphets
• Buy Rentokil Initial (RTO) by Bank of America
• Neutral Sage Group (SGE) by Goldman Sachs
• Buy 3i Group (III) by UBS